Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02497430 · ClinicalTrials.gov registry record
Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay
A clinical trial of Pregnancy and GBS, sponsored by Luminex Corporation.
- Completed
- Registry status
- 918
- Enrollment target
- 5
- Study locations
NCT02497430: Completed study of Pregnancy and GBS, sponsored by Luminex Corporation.
NCT02497430 is a study of Pregnancy and GBS that has completed, run by Luminex Corporation. The registered enrollment target is 918 participants, roughly in line with the 868-participant average among 191 other Pregnancy trials with a reported enrollment target. The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02497430, a study of Pregnancy and GBS, has completed, sponsored by Luminex Corporation.
- COMPLETED
- Registry status
- 918 participants
- Enrollment target
- 5
- Study locations
Study Summary
The ARIES GBS Assay is a real-time PCR based qualitative test designed to detect Group B Streptococcus (GBS) nucleic acid from Lim Broth enriched vaginal-rectal specimen swabs obtained from pregnant women between 35 - 37 weeks gestation.
Study Locations (5)
Florida
- Sacred Heart Health System - Pensacola
Michigan
- Detroit Medical Center University Laboratories - Detroit
New Mexico
- TriCore Reference Laboratories - Albuquerque
Pennsylvania
- Geisinger Medical Laboratories - Danville
Texas
- Baylor Scott & White - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 918 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-08 |
What the finished NCT02497430 record still lists
NCT02497430 is an observational study that tracks outcomes without assigning an intervention. The registered 918 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 868-participant average among 191 other Pregnancy trials with a reported enrollment target.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT02497430 lists 5 locations in 5 states (Florida, Michigan, New Mexico).
Frequently Asked Questions
What is clinical trial NCT02497430 about?
NCT02497430 is a clinical study titled "Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay". The ARIES GBS Assay is a real-time PCR based qualitative test designed to detect Group B Streptococcus (GBS) nucleic acid from Lim Broth enriched vaginal-rectal specimen swabs obtained from pregnant women between 35 - 37 weeks gestation.
What is the current status of trial NCT02497430?
This trial is currently completed. The enrollment target is 918 participants. The study started on 2016-03. Estimated completion is 2016-08.
What conditions does trial NCT02497430 study?
This clinical trial studies the following conditions: Pregnancy, GBS.
Who is sponsoring clinical trial NCT02497430?
This trial is sponsored by Luminex Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02497430 being conducted?
This trial has 5 study locations across Florida, Michigan, New Mexico, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02497430's enrollment target sits among peer trials
918 29th of 191 higher than 163 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05739955 · 918 participants · NA
Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia